Reverse-phase liquid chromatography with electrospray ionization/mass spectrometry for the quantification of pseudoephedrine in human plasma and application to a bioequivalence study

Abstract

A sensitive and selective reverse-phase liquid chromatography electrospray ionization mass spectrometry (LC-ESI-MS) method was developed and validated to quantify pseudoephedrine (CAS 90-82-4) in human plasma. Phenacetin was used as the internal standard (I.S.). Sample preparation was performed with a deproteinization step using acetonitrile. Pseudoephedrine and I.S. were successfully separated using gradient elution with 0.5% trifluoroacetic acid (TFA) in water and 0.5% TFA in methanol at a flow-rate of 0.2 mL/min. Detection was performed on a single quadrupole mass spectrometer by a selected ion monitoring (SIM) mode via electrospray ionization (ESI) source. The ESI source was set at positive ionization mode. The ion signals of m/z 166.3 and 180.2 were measured for the protonated molecular ions of pseudoephedrine and I.S., respectively. The lower limit of quantification (LLOQ) of pseudoephedrine in human plasma was 10 ng/mL and good linearity was observed in the range of concentrations 10–500 ng/mL (R² = 1). The intra-day accuracy of the drug containing plasma samples was more than 97.60% with a precision of 3.99–11.82%. The inter-day accuracy was 99.36% or more, with a precision of 7.65–18.42%.

By using this analytical method, the bioequivalence study of the pseudoephedrine preparation was performed and evaluated by statistical analysis of the log transformed mean ratios of pharmacokinetic parameters. All the results fulfilled the standard criteria of bioequivalence, being within the 80–125% range which is required by the Korea FDA, US FDA, and EMEA to conclude bioequivalence. Consequently, the developed reverse-phase LC-ESI-MS method was successfully applied to bioequivalence studies of pseudoephedrine in healthy male volunteers.

Key words

Bioequivalence - CAS 90-82-4 - Human plasma - LC-ESI-MS - Pharmacokinetics - Pseudoephedrine

• References

• 1 Kimura Y, Tani T, Kanbe T, Watanabe K.. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arz-neimittelforschung. 1985; 35 (7A) 1144-9
• 2 Lin ET, Brater DC, Benet LZ. Gas-liquid chromatographic determination of pseudoephedrine and norpseudoephe-drine in human plasma and urine. J Chromatogr. 1977; Oct 140 ((3)) 273-9
• 3 Lo LY, Land G, Bye A. Sensitive assay for pseudoephedrine and its metabolite, norpseudoephedrine in plasma and urine using gas-liquid chromatography with electron-capture detection. J Chromatogr. 1981; Feb 222 ((2)) 297-302
• 4 Brendel E, Meineke I, Henne EM, Zchunke M, De Mey C. Sensitive high-performance liquid chromatographic determination of pseudoephedrine in plasma and urine. J Chromatogr. 1988; Apr 426 ((2)) 406-11
• 5 Nieder M, Jaeger H. Sensitive quantification of pseudoephedrine in human plasma and urine by high-performance liquid chromatography. J Chromatogr. 1988; Jan 424 ((1)) 73-82
• 6 Guo P, Li Z, Li T, Wang X, Li F. Direct injection of plasma to determine pseudoephedrine by high performance liquid chromatography with column switching. Biomed Chromatogr. 1999; Feb 13 ((1)) 61-4
• 7 Macek J, Ptacek P, Klima J. Rapid determination of pseudoephedrine in human plasma by high-performance liquid chromatography. J Chromatogr B. 2002; Jan 766 ((2)) 289-94
• 8 Sun J, Wang G, Wang W, Zhao S, Gu Y, Zhang J, Huang M, Shao F, Li H, Zhang Q, Xie H. Simultaneous determination of loratadine and pseudoephedrine sulfate in human plasma by liquid chromatography-electrospray mass spectrometry for pharmacokinetic studies. J Pharm Biomed Anal. 2005; Sep 39 ((1–2)) 217-24
• 9 Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P.. Simultaneous quantification of fexofenadine and pseudoephedrine in human plasma by liquid chromatography/tandem mass spectrometry with electrospray ionization: method development, validation and application to a clinical study. Rapid Commun Mass Spectrom. 2006; 20(20): 3030-8
• 10 Ming M, Fang F, Yulan S, Shuangjin C, Han L. Development and evaluation of an efficient HPLC/MS/MS method for the simultaneous determination of pseudoephedrine and cetirizine in human plasma: application to phase-I pharmacokinetic study. J Chromatogr B. 2007; Feb 846 ((1–2)) 105-11
• 11 Nirogi RV, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Komarneni P. Quantification of pseudoephedrine in human plasma by LC-MS/MS using mosapride as internal standard. Biomed Chromatogr. 2007; Mar 21 ((3)) 241-8
• 12 Korea Food and Drug Administration KFDA Guideline for Bioequivalence Test. 2007
• 13 Lee YJ, Kim YG, Lee MG, Chung SJ, Lee MH, Shim CK. Analysis of bioequivalence study using log-transformed model. Yakhakhoeji. 2000; Aug 44 ((4)) 308-14
• 14 Shakya AK, Arafat TA, Abuawwad AN, Melhim M, Al-Ghani J, Yacoub MJ. Simultaneous determination of tripro-lidine and pseudoephedrine in human plasma by liquid chromatography-ion trap mass spectrometry. J Chromar-ogrB. 2009; Dec 877 ((32)) 4071-8
• 15 Lou HG, Yuan H, Jiang B. Simultaneous determination of paracetamol, pseudoephedrine, dextrophan and chlorpheniramine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2010; Mar 878 ((7–8)) 682-8